Navigation Links
Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring
Date:12/5/2008

s of crops without any modification other than delaying natural plant senescence. Senesco has partnered with leading-edge companies engaged in agricultural biotechnology and earns research and development fees for applying its gene-regulating platform technology to enhance its partners' products.

Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors, including, but not limited to: the development of the Company's gene technology; the approval of the Company's patent applications; the successful implementation of the Company's research and development programs and joint ventures; the success of the Company's license agreements; the acceptance by the market of the Company's products; success of the Company's preliminary studies and preclinical research; competition and the timing of projects and trends in future operating performance, our ability to maintain our continued listing standards for the next 12 months, as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

    Company Contact:
    Senesco Technologies, Inc.
    Bruce Galton
    Chief Executive Officer
    (bgalton@senesco.com)
    (732) 296-8400

    Investor Relations Contact:
    FD
    Brian Ritchie
    (brian.ritchie@f
'/>"/>
SOURCE  Senesco Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related biology technology :

1. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
2. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
3. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
4. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
5. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
6. Senesco Technologies to Present at BIO 2008 Business Forum
7. Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results
8. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
9. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
10. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
11. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Madison, WI (PRWEB) May 24, 2013 ... to the discovery and development of calcium-binding proteins ... publication of safety assessment study of apoaequorin ... an international journal published for the British Industrial ... the study was to investigate potential adverse effects, ...
(Date:5/23/2013)... Can economic incentives such as gift cards, ... the public to increase their donations of blood? , ... Business School Assistant Professor Mario Macis says the ... body of recent research that supports their argument, the ... of Science that the World Health Organization and national ...
(Date:5/23/2013)... 2013 The maker community is a ... inventions. They focus on learning practical skills while applying ... toward bringing their ideas to life via crowdfunding. A ... on making projects using biology. Glowing Plant has worked ... make them glow with bioluminescence genes, and has now ...
(Date:5/23/2013)... 23, 2013 BioTrends Research Group, one ... for specialized biopharmaceutical issues, finds that, unaided, one ... specialists reported that in the past six months, ... treatment) in anticipation of the next generation of ... when only 6 percent reported that they had ...
Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
... Journal Indicates Masimo SET May Also Reduce the Need for ... Jan. 30 Masimo (Nasdaq: ... Motion and Low Perfusion pulse oximetry, today announced that a ... January 2009 issue of the British Medical Journal ...
... Stock Exchange Symbol: MSEDMONTON, Jan. 30 /PRNewswire-FirstCall/ - ... in the treatment of multiple sclerosis (MS), today ... clinical trial evaluating dirucotide in patients with relapsing-remitting ... is for secondary progressive MS where it is ...
... CA The logic and memory functions of future electronic ... (billionths of a meter) instead of the many tens of ... way can be found to control domain walls, the ultrathin ... magnetic, electric, or other properties. , In a ...
Cached Biology Technology:New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 2New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 3New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 4New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 5BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 2BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 3BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 4BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 5Domain walls that conduct electricity 2Domain walls that conduct electricity 3Domain walls that conduct electricity 4Domain walls that conduct electricity 5
(Date:5/23/2013)... Public Health at Emory University, along with partners ... a $4 million grant over four years to ... and Exposome Research Center: Understanding Lifetime Exposures). The ... in the United States. , The HERCULES ... Environmental Health Sciences (NIEHS) of the National Institutes ...
(Date:5/23/2013)... wrapping of genomic DNA around nucleosomes in the ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich now ... be locally displaced from nucleosomes for transcription. , ... in the cell nucleus, wrapped around disk-shaped particles ... four different histone proteins and accommodating two loops ...
(Date:5/23/2013)... unnecessarily undergo surgery or harsh treatments because science ... aggressive forms of the disease. Researchers at Case ... are developing technology that allows patients to safely ... treatments or take drastic measures. , The project ... professor of biomedical engineering at Case Western Reserve ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Biochemistry: Unspooling DNA from nucleosomal disks 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... healthy men decline as they get older. As sleep ... in the amount of sleep a healthy older man gets ... to a study published in the April 1st issue of ... MD, PhD, of the University of Chicago, focused on 12 ...
... state-of-the-art technique to map neurons in the spinal cord ... a surprising pattern of activity that regulates the speed ... implications for treating injured human spinal cords and Parkinson’s ... The study, "A Topographic Map of Recruitment in Spinal ...
... delivery system using microspheres of a biodegradable polymer may not ... but also appears to stimulate an immune response that traditional ... their findings today at the ASM Biodefense and Emerging Disease ... that block entry into the cell. In the case ...
Cached Biology News:Fast and slow -- How the spinal cord controls the speed of movement 2Biodegradable microspheres deliver time release vaccines, stimulate different immune response 2
In Western blotting antibodies recognize 94 K protein band, which corresponds to S-layer protein...
... is based on the simple, highefficiency Tn5 ... and Reznikoff, and by York et al. ... and inversions by intramolecular transposition into DNA ... Although most researchers will be interested in ...
High affinity antibodies recognizes HSP70 protein from human cardiac tissue. Could be used for Westerb blotting application, ELISA....
... knockout or alter genes on the E.coli ... recombination allows the exchange of genetic information in ... An FRT-flanked kanamycin resistance marker cassette is supplied ... replace a gene on the E.coli ...
Biology Products: